Data as of Sep 26, 2026 · Based on 4,029,442 AI responses across 13,338 prompts · See how Parse measures this
Allucent is a global full-service contract research organization that partners with small- and mid-sized biopharma to accelerate clinical development from early-stage research through post-approval. It provides end-to-end solutions across therapeutic areas such as oncology, neuroscience, infectious diseases, and rare or advanced therapies, including data management, biostatistics, regulatory strategy, pharmacovigilance, and site/network management. The company emphasizes a flexible, partner-led approach and deep therapeutic expertise to help clients overcome development challenges and bring new therapies to patients worldwide.
Parse Score
AI recommends Allucent for rare disease recruitment, emphasizing site networks, registries, and KOL referrals to reach hard-to-find patients.
AI rates Allucent better than rivals on size
Worse than rivalsBetter than rivals